# PBS Biotech

sells single-use Vertical-Wheel bioreactors (including a 15L system for cell-therapy scale-up) using a low-shear vertical impeller design documented in peer-reviewed research to predict maximum achievable cell density before oxygen-transfer becomes limiting for iPSC aggregate cultures.


Source: https://cn.bioecon.ru/companies/pbs-biotech/
Updated: 2026-08-14

- 国家: United States

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | 累计融资$5868万（最近一轮为2025年1月的$1700万） | https://www.prnewswire.com/news-releases/pbs-biotech-expands-leadership-team-and-secures-17-million-in-growth-capital-to-accelerate-delivery-of-next-generation-cell-and-regenerative-therapies-302341410.html |
| 产能 | 截至 2025 年扩大产能以支持超过 $100M 的年收入 | https://www.prnewswire.com/news-releases/pbs-biotech-expands-leadership-team-and-secures-17-million-in-growth-capital-to-accelerate-delivery-of-next-generation-cell-and-regenerative-therapies-302341410.html |
| 认证 | 通过ISO 9001:2015认证；产品符合USP Class VI和/或ISO 10993标准 | https://pbsbiotech.com/company, https://pbsbiotech.com/pbs-15-bioreactors |
| 监管批准 | 产品按照cGMP标准生产，并提供符合21 CFR Part 11要求的软件选项 | https://pbsbiotech.com/products-for-cell-therapy, https://www.pbsbiotech.com/products-for-cell-therapy |
| 生产基地 | 位于美国加州卡马里奥（Camarillo）的63,800平方英尺设施 | https://pbsbiotech.com/company |
| 员工人数 | 截至2026年，员工约104-105人 | https://getlatka.com/companies/pbsbiotech.com |
| 营收 | 2025年为$31.6M [中等置信度] | https://getlatka.com/companies/pbsbiotech.com |

独立来源: getlatka.com, prnewswire.com

## 技术

- [高密度细胞培养系统](https://cn.bioecon.ru/technology/high-cell-density-culture-systems/)